D-chiro-inositol: Research, Dosing, and Where to Buy in 2026
A research-first profile for D-chiro-inositol (DCI, d-chiro inositol), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
D-chiro-inositol is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 1 transcript dosing protocol for D-chiro-inositol, each linked to its source.
- Also indexed as DCI, d-chiro inositol.
- 1 aggregated dosing-protocol mention from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is D-chiro-inositol?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
D-chiro-inositol Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
| Speaker | Source | Timestamp | Protocol | Evidence |
|---|---|---|---|---|
| Lucas Aoun | Muscle Builders, Vitamin D, Ashwagandha, GDAs & More with Lucas Aoun | 00:09:40 | Lucas reported a dosing protocol of 1 gram per day orally for one month, based on a human trial of 10 male volunteers. | anecdotal |
Where to Buy D-chiro-inositol in 2026
No tracked vendor recommendations for D-chiro-inositol yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about D-chiro-inositol. Each line links to the original source.
- "Spontaneous menses resumed in 28 (84.85%) young women on MI + DCI, compared with withdrawal bleeding in 34 (100%) on CHC." · Kachhawa G et al, 2022 PubMed
- "Regular menstrual cycles were established in 9 (27.27%) young women with MI + DCI (P = 0.001) and 30 (88.23%) with CHC (P < 0.001)." · Kachhawa G et al, 2022 PubMed
- "Three months after stopping the treatment, 24 young women (85.71%) on MI + DCI and 25 (73.53%) on CHC continued to have spontaneous cycles." · Kachhawa G et al, 2022 PubMed
- "According to Lucas, the compound was associated with reduced serum levels of estrone by 85%, estradiol went down by 14.4%, increased serum testosterone levels by 23.4%, and also raised DHEA levels by 13.8%." · Lucas on "Muscle Builders, Vitamin D, Ashwagandha, GDAs & More with Lu" @ 9:48
Research and Studies
8 PubMed-indexed papers reference D-chiro-inositol. Top 8 shown.
Legal Status
D-chiro-inositol is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is D-chiro-inositol FDA-approved?
D-chiro-inositol is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
What dosing is reported for D-chiro-inositol?
This page aggregates 1 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.
How much research has been published on D-chiro-inositol?
8 PubMed-indexed paper(s) reference D-chiro-inositol in our current research feed. See the Research and Studies section above for citations.